Edition:
India

Orgenesis Inc (ORGS.OQ)

ORGS.OQ on NASDAQ Stock Exchange Capital Market

8.35USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$8.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$16.34
52-wk Low
$8.00

Chart for

About

Orgenesis Inc. is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company's subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced... (more)
No analyst recommendations are available for .

Overall

Beta: 2.20
Market Cap(Mil.): $54.51
Shares Outstanding(Mil.): 121.14
Dividend: --
Yield (%): --

Financials

BRIEF-Orgenesis Reports Q1 Loss Per Share Of $0.52

* ORGENESIS REPORTS 42% INCREASE IN REVENUE FOR THE FIRST QUARTER OF FISCAL 2018

19 Apr 2018

BRIEF-Orgenesis Files For Mixed Shelf Of Up To $100 Mln

* ORGENESIS INC FILES FOR MIXED SHELF OF UP TO $100 MILLION – SEC FILING‍​ Source text: (http://bit.ly/2HLAOaJ)

20 Mar 2018

Earnings vs. Estimates

No consensus analysis data available.